References– Victoria Angel Registry of Hope
Aird W., et al. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Bone Marr Trans 1992; 9:487-90.
Ballen KK, Spitzer TR, Yeap B, Steve M, Dey BR, Attar E et al. Excellent disease-free survival after double cord blood transplantion using a reduced intensity chemotherapy only conditioning regimen in a diverse adult population. ASH Annual Meeting Abastracts 2005; 106: 2048.
Barker JN, Weisdorf DJ, DeFor TE et al. Transplantation of 2 partially HLA matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105:1343-1347.
Bhatia M, Walters M. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant, 2008; 41:109-17.
Boelens JJ, Aldenhoven M, Purtill D,et al. Eurocord; Inborn Errors Working Party of European Blood and Marrow Transplant group; Duke University Blood and Marrow Transplantation Program; Centre for International Blood and Marrow Research. Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood. 2013;121:3981-7.
Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc National Acad Sci USA 2003; 100: 645– 50.
Carroll J. Human cord blood for the hypoxic-ischemic neonate. Pediatr Res. 2012;71:459-63.
Chhabra P, Brayman KL. Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med.
CLINICAL TRIAL: Duke University, Neonatal Hypoxic Ischemic Encephalopathy; Phase 1 Clinical trial NCT00593242 http://clinicaltrials.gov/ct2/show/NCT00593242 (Accessed July 31, 2013)
Cutler C, Ballen KK. Improving outcomes in umbilical cord blood transplantation: state of the art. Blood Rev. 2012;26:241-6. Review.
Da Costa V, O’Grady G, Jackson L, Kaylie D, Raynor E. Improvements in sensorineural hearing loss after cord blood transplant in patients with mucopolysaccharidosis. Arch Otolaryngol Head Neck Surg. 2012;138:1071-6.
Eapen M, Rubinstein P, Zhang JM et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lancet 2007; 369: 1947–1954.
Escolar ML, Poe MD, Provenzale JM et al. Transplantion of umbilical cord blood in babies with infantile Krabbe’s disease. NEJM 2005; 352: 2069-2081.
Fiorina P, Voltarelli J, Zavazava N. Immunological applications of stem cells in type 1 diabetes. Endocr Rev. 2011;32:725-54.
Franqoul H et al. Unrelated UCB transplantation in children with immune deficiency: results of a multicenter study. Bone Marrow Transplant 2009, Jun
Frey M et al. Umbilical cord blood cell transplantation. Semin Oncol Nurs 2009 May; 25(2): 115 -9.
Fruchtman SM, Hurlet A, Dracker R et al. The successful treatment of severe aplastic anemia with autologous cord blood transplantation. Biol Blood Marrow Transplant, 2004; 10: 741-2.
Garbuzova-Davis S. et al. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS ONE. 2008 June 25; 3(6).
Garbuzova-Davis S, Rodrigues MC, Mirtyl S et al. Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS. PLoS One. 2012;7:e31254.
Gluckman E, Koegler G, Rocha V. Human leukocyte antigen matching in cord blood transplantation. Semin Hematol 2005; 42: 85-90.
Gluckman E, Rocha V, Arcese W, Michael G, Sanz G, Chan KW et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397-407.
Goldstein G, Toren A, Nagler A. Transplantation and other uses of human umbilical cord blood and stem cells. Curr Pharm Des, 2007; 13:1363-73.
Haller, M.J. et al. Autologous umbilical cord blood infusion for type 1 diabetes. Exp. Hematology. 2008; 36: 710-715.
Harris D, Rogers I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther 2007; 2:301-309.
Hau S, Reich D, Scholz M et al. Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro. BMC Neurosci, 2008; 9:30.
Hayani A, et al. First report of autologous cord blood transplantation in treatment of a child with leukemia. Pediatrics. 2007; 119:296-300.
Jubert C, Wagner E, Bizier S, Vachon MF, Duval M, Champagne M. Length of cord blood unit cryopreservation does not impact hematopoietic engraftment. Transfusion 2008; 48:2028-29.
Kobylka, P. “Preservation of Immunological and Colony-Forming Capacities of Long-Term (15 years) Cryopreserved Cord Blood Stem Cells. Transplantation”. 1998;65 (9):1275-1278.
Koestenbauer S et al. Protocols for Hematopoietic stem cell expansion from UCB. Cell Transplant 2009 May 6: CT-2012.
Kurtzberg et al. Update on umbilical cord blood transplantation. Current Opinion Pediatrics, 2009 Feb: 21(1): 22-9.
Kurtzberg J, Prasad VK, Carter SL, et al. Results of the Cord Blood Transplantation Study: clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematological malignancies. Blood 2008; 112: 4318-4327.
Kwon M, Balsalobre P, Serrano SD, et al. Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders. Biol Blood Marrow Transplant. 2013 ;19:143-9.
Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N. Engl. J Med 2001; 344: 1815–1822.
Liao Y, Geyer MB, Yang AJ, Cairo MS. Cord blood transplantation and stem cell regenerative potential. Exp Hematol. 2011;39:393-412.
Lichtenstein, P., et al. “Environmental and Heritable Factors in the Causation of Cancer”. New England Journal of Medicine. 2000;343 (2):78-85.
Liu H, Rich ES, Godley L et al. Reduced-intensity conditioning with combined haploidentical and cord blood
transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood. 2011;118:6438-45.
Locatelli F, Kabbara N, Ruggeri A, et al. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood. 2013 May 21. [Epub ahead of print]
Majhail N, Weisdorf D, Wagner J et al. Comparable results of umbilical cord blood and HLA-matched sibling donor preparative regimen for advanced Hodgkin lymphoma. Blood, 2006; 107: 3804-7.
Martin HR, Poe MD, Provenzale JM et al. Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy. Biol Blood Marrow Transplant. 2013;19:616-24.
Nagler A. Recent Developments in human ucb transplantation in Israel. Biol Blood Marrow Transplant 2008, Jan; 14:99-103.
Neitfeld J, Pasquini M, Logan B, Verter F, Horowitz M. Lifetime probabilities of hematopoietic stem cell transplantation in the US. 2008; 13:316-22.
Newman M Davis C, Borlongan C et al. Transplantion of human umbilical cord blood cells in the repair of CNS diseases. Expert Opin. Biol Ther 2004; 4:121-30.
Okamura K et al. Successful Cord Blood Transplantation using a reduced-intensity conditioning regimen for advanced childhood-onset cerebral adrenoleukodystrophy. Pediatric Transplant, 2009 May; 13:130-133.
Pasquini MC et al. The likelihood of hematopoietic stem cell transplantation (HCT) in the United States: implications for umbilical cord blood storage. Blood 2005; 11.
Reedberg, L. “Cancer Rates for Children Worry Experts”. San Francisco Chronicle. September 17, 1997.
Rocha V, Chastang C, Souillet G et al. Related cord blodo transplants: the Eurocord experience from 78 transplants. Eurocord Transplant group, Bone Marrow Transplant, 1998; 21 (supple. 3): 559-62.
Rocha V, Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients, Bone Marrow Transplant, 2008; 41:207-14.
Rocha V, Labopin M, Ruggeri A et al. Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies. Transplantation. 2013;95:1284-91.
Rosenkranz K, Meier C Umbilical cord blood cell transplantation after brain ischemia–from recovery of function to cellular mechanisms. Ann Anat. 2011;193:371-9.
Sandberg P et al. Umbilical cord blood derived stem cells and brain repair, Ann NY Acad Sci 2005: 1049:67-83.
Scaradavou A, Brunstein CG, Eapen M et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood. 2013;121:752-8.
Shenoy S. Umbilical cord blood: an evolving stem cell source for sickle cell disease transplants. Stem Cells Transl
Silversides A. Cord Blood Bank plans evolve with ‘glacial speed”. Published in Canadian Medical Association Journal (CMAJ), 2009 Jun 23; 180(13): 1295-6.
Staba SL, Escolar ML, Poe M, et al. Cord blood transplants from unrelated donors in patients with Hurler’s syndrome.
NEJM 2004; 305: 1960-1969.
Urban C, Schwinger W Benesch M et al. Autologous cord blood transplantation in children with acute lymphoblastic leukemia and central nervous system relapse, Pediatrics, 2007; 119: 1042 -43.
Van Besien K, Liu H, Jain N, Stock W, Artz A. Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications. Biol Blood Marrow Transplant. 2013;19:682-91.
Wagner E, Duval M, Dalle JH, Morin H, Bizier S, Champagne J, Champage MA. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion 2006; 46:1190-8.
Wagner J, Kernan N, Steinbuch M, et al. Allogeneic sibling umbilical cord blood transplantion in children with malignant and non-malignant disease. Lancet 1995; 346: 214 -219.
Willert J, Purdon T, Harris D. Umbilical Cord Blood – Biology, Banking and Therapeutic Use. US Obstetrics and
Gynecology – Neonatal Medicine. 2008.
Willert, J. Low risk of transplant-related complications with genetically related cord blood stem cells. 2008; ASBMT
Annual meeting presentation.
Willing A, Eve D, Sanbertg P. Umbilical cord blood transfusions for prevention of progressive brain injury and induction of neural recovery: an immunological perspective. Regen Med, 2007; 2:457 -64
World Marrow Donor Association (WMDA) Annual Report, 2006 – 2011
Zietlow R et al. et al. Transplantation of Human Umbilical cord blood cells in the repair of CNS diseases. Expert Opin Biol Ther. 2004, Feb; 4(2): 121-30.